Press release
Global Psychedelic Drugs Market Report- Size, Current Trends, Regional Business Landscape And Development Scope To 2021
The Global Psychedelic Drugs Market research report studies the competitive development of the market, such as agreements, new product launches, expansions, and acquisitions in the market. In addition, Global Psychedelic Drugs Market provides a region-wise study of the market, including North America, Asia Pacific, Latin America, Middle East, Africa, and Europe. Global Psychedelic Drugs Market helps stakeholders understand market players and analyze the top 25 organizations based on their product footprint, market strength, and position. Moreover, Global Psychedelic Drugs Market also focuses on market performance during the estimated period.Get FREE PDF Sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5096374
Market segment by players, this report covers
- COMPASS Pathways PLC
- Pfizer
- Eli Lilly
- GlaxoSmithKline
- Cybin Inc
- Field Trip Health
- ATAI Life Sciences
- NUMINUS WELLNESS
- MindMed
- HAVN Life Sciences
- Seelos Therapeutics
- Jannsen
- Acadia Pharmaceuticals
- Intellipharmaceutics
- Revive Therapeutics
- Mydecine Innovations Group
- Red Light Holland
- Braxia Scientific
- Mind Cure Health
- Entheon Biomedical
The Psychedelic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Psychedelic Drugs size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Psychedelic Drugs market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Psychedelic Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Psilocybin
- LSD
- MDMA
- DMT
- Ketamine
- Others
Market segment by Application, can be divided into
- Depressive Disorders
- Post-Traumatic Stress Disorders
- Substance Abuse Disorders
- Obsessive Compulsive Disorders
- Others
Get Discount on Purchase this Report @ https://www.reportsnreports.com/purchase.aspx?name=5096374
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Psychedelic Drugs
1.2 Classification of Psychedelic Drugs by Type
1.2.1 Overview: Global Psychedelic Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Psychedelic Drugs Revenue Market Share by Type in 2020
1.2.3 Psilocybin
1.2.4 LSD
1.2.5 MDMA
1.2.6 DMT
1.2.7 Ketamine
1.2.8 Others
1.3 Global Psychedelic Drugs Market by Application
1.3.1 Overview: Global Psychedelic Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Depressive Disorders
1.3.3 Post-Traumatic Stress Disorders
1.3.4 Substance Abuse Disorders
1.3.5 Obsessive Compulsive Disorders
1.3.6 Others
1.4 Global Psychedelic Drugs Market Size & Forecast
1.5 Global Psychedelic Drugs Market Size and Forecast by Region
1.5.1 Global Psychedelic Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Psychedelic Drugs Market Size by Region, (2016-2021)
1.5.3 North America Psychedelic Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Psychedelic Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Psychedelic Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Psychedelic Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Psychedelic Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Psychedelic Drugs Market Drivers
1.6.2 Psychedelic Drugs Market Restraints
1.6.3 Psychedelic Drugs Trends Analysis
2 Company Profiles
2.1 COMPASS Pathways PLC
2.1.1 COMPASS Pathways PLC Details
2.1.2 COMPASS Pathways PLC Major Business
2.1.3 COMPASS Pathways PLC Psychedelic Drugs Product and Solutions
2.1.4 COMPASS Pathways PLC Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 COMPASS Pathways PLC Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Psychedelic Drugs Product and Solutions
2.2.4 Pfizer Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Psychedelic Drugs Product and Solutions
2.3.4 Eli Lilly Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eli Lilly Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Psychedelic Drugs Product and Solutions
2.4.4 GlaxoSmithKline Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 Cybin Inc
2.5.1 Cybin Inc Details
2.5.2 Cybin Inc Major Business
2.5.3 Cybin Inc Psychedelic Drugs Product and Solutions
2.5.4 Cybin Inc Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Cybin Inc Recent Developments and Future Plans
2.6 Field Trip Health
2.6.1 Field Trip Health Details
2.6.2 Field Trip Health Major Business
2.6.3 Field Trip Health Psychedelic Drugs Product and Solutions
2.6.4 Field Trip Health Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Field Trip Health Recent Developments and Future Plans
2.7 ATAI Life Sciences
2.7.1 ATAI Life Sciences Details
2.7.2 ATAI Life Sciences Major Business
2.7.3 ATAI Life Sciences Psychedelic Drugs Product and Solutions
2.7.4 ATAI Life Sciences Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 ATAI Life Sciences Recent Developments and Future Plans
2.8 NUMINUS WELLNESS
2.8.1 NUMINUS WELLNESS Details
2.8.2 NUMINUS WELLNESS Major Business
2.8.3 NUMINUS WELLNESS Psychedelic Drugs Product and Solutions
2.8.4 NUMINUS WELLNESS Psychedelic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 NUMINUS WELLNESS Recent Developments and Future Plans
and more...
+ 1 888 391 5441
sales@reportsandreports.com
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Psychedelic Drugs Market Report- Size, Current Trends, Regional Business Landscape And Development Scope To 2021 here
News-ID: 2485128 • Views: …
More Releases from ReportsnReports
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Psychedelic
Psychedelic Therapeutics Market in 2025 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Psychedelic Therapeutics Market By Origin of Psychedelic Substance (Synthetic Substances and Natural Substances), Type of Psychedelic Substance (GHB, Ketamine, MDMA, Psilocybin, DMT, Ayahuasca and LSD), Target Therapeutic Area (Depression and Anxiety Disorders, Pain Disorders, Sleep-Related Disorders and Trauma)- Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
Ibogaine by David Dardashti Forges Strategic Partnership with Psychedelic Univer …
MIAMI, FL - June 20, 2025 - Ibogaine by David Dardashti, a pioneering leader in ibogaine-assisted therapy and led by visionary David Dardashti, today announced a groundbreaking collaboration with a Psychedelic University. This strategic partnership aims to establish robust internship opportunities for students passionate about contributing to the rapidly evolving psychedelic field, with initial networking prospects to be explored at the highly anticipated Psychedelic Conference 2025. The initiative is further…
Psychedelic Drugs Market Growth, Status & Opportunities 2034
On March 21, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Psychedelic Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
The Psychedelic Drugs Market: Exploring the Therapeutic Potential
The psychedelic drugs market is undergoing a significant resurgence, driven by a renewed interest in their potential therapeutic applications. After decades of legal restrictions and limited research, these substances are now being investigated for their potential to treat a range of mental health conditions, including depression, anxiety, post-traumatic stress disorder (PTSD), and addiction. This post will delve into the market, exploring its size, share, opportunities, challenges, demand, and trends.
Market Size…
Psychedelic Drugs Market Size, Overview & Leading 2024-2033
The new report published by The Business Research Company, titled ""Psychedelic Drugs Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the psychedelic drugs market size has grown rapidly in recent years. It will grow from $4.88 billion in…
PSYCHEDELIC CHURCH SOUL TRIBES INTERNATIONAL MINISTRIES PRESENTS "SHROOM BREATH …
PSYCHEDELIC CHURCH SOUL TRIBES INTERNATIONAL MINISTRIES PRESENTS "SHROOM BREATH 369" - A TRANSFORMATIONAL PSYCHEDELIC HEALING EXPERIENCE
DETROIT, MICHIGAN -- Psychedelic Church Soul Tribes International Ministries ("Soul Tribes" or the "Organization"), a 508(c)(1)(a) non-profit dedicated to psychedelic therapy and spiritual healing, announces its upcoming event, "Shroom Breath 369," on February 3rd, 2024, at the esteemed St. Regis in Detroit, Michigan.
Title: Shroom Breath 369 - A Psychedelic Healing Experience
Date: February 3rd, 2024
Time: 6:00…
